Edoardo Schneider

1.1k citations
8 papers · 718 · 1 hit paper · h-index 7

Impact in

    • SARS-CoV-2 and COVID-19 Research
    • COVID-19 Clinical Research Studies
    • SARS-CoV-2 detection and testing
    • Viral gastroenteritis research and epidemiology
  • Neurology top 10%
    • Long-Term Effects of COVID-19

Papers in

    • COVID-19 Clinical Research Studies 4
    • SARS-CoV-2 and COVID-19 Research 2
    • Viral gastroenteritis research and epidemiology 1

Edoardo Schneider

8 papers receiving 708 citations

Edoardo Schneider's Hit Papers

Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia 2021 · 314 citations
3140+1+3Years since publication100200300

Peers

Edoardo Schneider
Comparison fields: 5 of 83
  • Infectious Diseases 464
  • Neurology 118
  • Animal Science and Zoology 64
  • Immunology 93
  • Sensory Systems 16
Replace Matt Chandler with:
Matt Chandler United Kingdom
Roxana Paraschiv United Kingdom
Lorena Donnici Italy
Saman Fatihi India
Surabhi Rathore India
Mónica Becerra-Wong Ecuador
Jinwook Choi South Korea
Biao Zhou China
Jessica R. Shaw United States
Huiwen Zheng China
Edoardo Schneider relative to Matt Chandler United Kingdom Matt Chandler's profile →
Citations per field
00.5×1.5×
Matt Chandler · 1×
Citations per year

Countries citing papers authored by Edoardo Schneider

Since Specialization
Citations

This map shows the geographic impact of Edoardo Schneider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edoardo Schneider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edoardo Schneider more than expected).

Fields of papers citing papers by Edoardo Schneider

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edoardo Schneider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edoardo Schneider. The network helps show where Edoardo Schneider may publish in the future.

Co-authors

The 25 scholars most cited alongside Edoardo Schneider, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Edoardo Schneider Line = papers co-authored together Edoardo Schneider links everyone, so they are left out of the graph.

All Works

8 of 8 papers shown
#Work
1
Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia
Hit paper breakdown →
2021314
2 2020273
3 202133
4 202133
5 202024
6 202324
7 202315
8 20242

About Edoardo Schneider

Edoardo Schneider is a scholar working on Infectious Diseases, Physiology, Cell Biology, Computational Theory and Mathematics and Immunology, having authored 8 papers that have together received 718 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (4 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Viral gastroenteritis research and epidemiology (1 paper), CRISPR and Genetic Engineering (1 paper), Computational Drug Discovery Methods (1 paper), Complement system in diseases (1 paper), Mosquito-borne diseases and control (1 paper) and Virus-based gene therapy research (1 paper). The work is most often cited by research in Infectious Diseases (464 citations), Neurology (118 citations), Animal Science and Zoology (64 citations), Immunology (93 citations) and Sensory Systems (16 citations). Edoardo Schneider has collaborated with scholars based in Italy, United Kingdom and Spain. Frequent co-authors include Mauro Giacca, Luca Braga, Rossana Bussani, Chiara Collesi, Hashim Ali, Serena Zacchigna, Furio Silvestri, Lorena Zentilin, Andrea Colliva and Giorgio Berlot. Their work appears in journals such as mBio, Antiviral Research, Frontiers in Cardiovascular Medicine, Cell Reports and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact